New Delhi: The second dose trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, for children between 2-6 years will begin at the All India Institute of Medical Sciences (AIIMS) in New Delhi next week.
According to news agency ANI, the children in the above-mentioned age group have already been inoculated with the first dose of Covaxin.
AIIMS Delhi is a trial centre for the vaccine for those below 18 years. Agency sources also said that Covaxin’s second dose has already been administered to children between 6 and 12 years at AIIMS, Delhi.
The clinical trial results are expected in a month’s time after the completion of trials of all age groups. The trial is being conducted in three phases by segregating children into various age categories.
ALSO READ: Bharat Biotech Dossier Under Review For Covaxin’s Emergency Use Listing: WHO
Bhubaneswar: Tigress Zeenat, who travelled nearly 200 km over two weeks from Odisha's Similipal, avoiding…
Bhubaneswar: The Odisha Government has dissolved the governing bodies or managing committees of all Non-Government…
New Delhi: President Droupadi Murmu on Monday appointed former Supreme Court judge Justice V Ramasubramanian…
Bhubaneswar: Marking a significant development in eco-friendly transport in Odisha, a tripartite Memorandum of Understanding…
Mumbai: After veteran actor Mukesh Khanna, noted poet Kumar Vishwas left netizens irked with his…
Bhubaneswar: A major fire erupted at a pressure cooker company godown at Satyanagar in Bhubaneswar…
This website uses cookies.